US Patent 7718774 TES7 and antibodies that bind thereto
Patent 7718774 was granted and assigned to MacroGenics on May, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+303 characters)
Article
Patent abstract
The invention provides the identification and characterization of disease and cancer-associated antigen, TES7. The invention also provides a family of monoclonal antibodies that bind to antigen TES7, methods of diagnosing and treating various human cancers and diseases that express TES7.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Jennie P. Mather0
Tony W. Liang0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07718774 TES7 and antibodies that bind thereto US Patent 7718774 TES7 and antibodies that bind thereto
Infobox
Patent Number
07718774
Patent Number
7718774
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07718774 TES7 and antibodies that bind thereto
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07718774
Date of patent
May 18, 2010
Patent application number
11937470
Date Filed
November 8, 2007
Patent primary examiner
Find more entities like US Patent 7718774 TES7 and antibodies that bind thereto
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.